Kyu-Young Lee
Director/Board Member at BENO TNR, INC.
Network origin in Kyu-Young Lee first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Packaged Software | 8 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kyu-Young Lee via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Seoul National University | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| KOREA ROBOT MANUFACTURING CO.,LTD. | Semiconductors | Chief Executive Officer Director of Finance/CFO Comptroller/Controller/Auditor | |
| WESTRISE CO., LTD. | Specialty Stores | Chief Executive Officer Comptroller/Controller/Auditor | |
| SMEC CO.,LTD | Specialty Telecommunications | Director/Board Member | |
| SONID INC. | Electronic Equipment/Instruments | Chief Executive Officer | |
| Exax Nfc Co. Ltd. | Director/Board Member | ||
| Benobio Co., Ltd. | Chief Executive Officer | ||
| Hanyang University | College/University | Graduate Degree | |
| Yonsei University | College/University | Undergraduate Degree | |
J&J Investment Co., Ltd.
 J&J Investment Co., Ltd. Miscellaneous Commercial ServicesCommercial Services J&J Investment Co. Ltd. provides management consulting services. The company was founded on April 2, 2002 and is headquartered in Pohang-si, South Korea. | Miscellaneous Commercial Services | Chief Executive Officer | |
| FUTURECORE CO.,LTD. | Semiconductors | Director/Board Member | |
Nano Pharmasolutions, Inc.
 Nano Pharmasolutions, Inc. Pharmaceuticals: MajorHealth Technology Nano Pharmasolutions, Inc. is a pharmaceutical company based in an undisclosed location. Nano Pharmasolutions is developing a dry powder for inhalation (DPI) formulation of remedesivir to fight COVID-19. The American company's platform is based on physical vapor deposition (PVD) technology, which allows them to make drug nanoparticles with no excipients or solvents. These nanodrug particles can be used in various forms such as pills, nasal sprays, creams/salves, inhalers, and eye drops. The private company's nanotransformer™ technology can create an e-8 torr vacuum, and it uses carrier solids selected from hydrophilic pharmaceutical excipients to deposit vapor phase drugs as nanoparticles on fast-moving carriers. The company was founded by Kay Olmstead, Saeyeon Lee, Seok-Keun Koh, and Kay Olmstead has been the CEO since incorporation. | Pharmaceuticals: Major | Founder |
Statistics
International
| South Korea | 12 |
| United States | 2 |
Sectoral
| Consumer Services | 4 |
| Electronic Technology | 4 |
| Retail Trade | 2 |
| Communications | 2 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 15 |
| Chief Executive Officer | 8 |
| Independent Dir/Board Member | 4 |
| Graduate Degree | 3 |
| Comptroller/Controller/Auditor | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Jib-Hoon Jung | 8 |
| Sung-Soo Kim | 4 |
| Chang-Hyun Kim | 4 |
| Young-Tea Yun | 3 |
| Jae-Jun Dong | 3 |
| Kay Olmstead | 2 |
| Seung-Woo Lee | 1 |
| Aldrin R Denny | 1 |
- Stock Market
- Insiders
- Kyu-Young Lee
- Company connections
